21
Bariatric Surgery and Pharmacokinetics of Valsartan
Condition(s):Obesity, MorbidLast Updated:July 6, 2022Recruiting
Valsartan: 509 Clinical Trials, Page 3 of 51
Hide Studies Not Open or Pending
22
Sacubitril/Valsartan in Resistant Hypertension
Condition(s):Resistant Hypertension; Blood PressureLast Updated:December 1, 2020Unknown status
23
The Drug-drug Interaction of SP2086 and Valsartan
Condition(s):Type 2 DiabetesLast Updated:June 28, 2016Completed
24
Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg
Condition(s):HealthyLast Updated:August 7, 2015Completed
25
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
Condition(s):Chronic Heart Failure; Sleep Apnea SyndromeLast Updated:June 15, 2021Completed
26
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Condition(s):Hypertrophic CardiomyopathyLast Updated:January 11, 2021Completed
27
Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD
Condition(s):Myocardial Injury; Connective Tissue DiseasesLast Updated:January 7, 2020Unknown status
28
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
Condition(s):Hematopoietic Stem Cell Transplantation; CardiotoxicityLast Updated:April 3, 2020Unknown status
29
Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers
Condition(s):Hypertension, HyperlipidemiaLast Updated:August 8, 2013Completed
30
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
Condition(s):HypertensionLast Updated:March 28, 2017Completed